[go: up one dir, main page]

IT1254315B - Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf. - Google Patents

Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf.

Info

Publication number
IT1254315B
IT1254315B ITRM920223A ITRM920223A IT1254315B IT 1254315 B IT1254315 B IT 1254315B IT RM920223 A ITRM920223 A IT RM920223A IT RM920223 A ITRM920223 A IT RM920223A IT 1254315 B IT1254315 B IT 1254315B
Authority
IT
Italy
Prior art keywords
antibodies
idiotypic monoclonal
monoclonal antibodies
tnf
direct against
Prior art date
Application number
ITRM920223A
Other languages
English (en)
Inventor
Angelo Corti
Original Assignee
Mini Ricerca Scient Tecnolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mini Ricerca Scient Tecnolog filed Critical Mini Ricerca Scient Tecnolog
Priority to ITRM920223A priority Critical patent/IT1254315B/it
Publication of ITRM920223A0 publication Critical patent/ITRM920223A0/it
Priority to EP19930830121 priority patent/EP0568500A1/en
Publication of ITRM920223A1 publication Critical patent/ITRM920223A1/it
Application granted granted Critical
Publication of IT1254315B publication Critical patent/IT1254315B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6873—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting an immunoglobulin; the antibody being an anti-idiotypic antibody

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Sono descritti anticorpi monoclonali anti-idiotipici capaci di riconoscere e legare almeno un idiotopo di un anticorpo anti-TNF.
ITRM920223A 1992-03-27 1992-03-27 Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf. IT1254315B (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITRM920223A IT1254315B (it) 1992-03-27 1992-03-27 Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf.
EP19930830121 EP0568500A1 (en) 1992-03-27 1993-03-26 Anti-idiotype monoclonal antibodies directed against anti-TNF antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920223A IT1254315B (it) 1992-03-27 1992-03-27 Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf.

Publications (3)

Publication Number Publication Date
ITRM920223A0 ITRM920223A0 (it) 1992-03-27
ITRM920223A1 ITRM920223A1 (it) 1993-09-27
IT1254315B true IT1254315B (it) 1995-09-14

Family

ID=11400882

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920223A IT1254315B (it) 1992-03-27 1992-03-27 Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf.

Country Status (2)

Country Link
EP (1) EP0568500A1 (it)
IT (1) IT1254315B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9225448D0 (en) * 1992-12-04 1993-01-27 Erba Carlo Spa Improved synthesis of polymer bioactive conjugates
AT409086B (de) * 1999-11-16 2002-05-27 Igeneon Krebs Immuntherapie Neue verwendung von antikörpern als impfstoffe
CA2696210A1 (en) * 2007-08-28 2009-03-12 Abbott Biotechnology Ltd. Compositions and methods comprising binding proteins for adalimumab

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990001066A1 (en) * 1988-07-26 1990-02-08 Bio-Research Laboratories, Inc. Porcine polyclonal and monoclonal antibodies
WO1992003145A1 (en) * 1990-08-27 1992-03-05 Peptide Technology Ltd. Method of treating viral infection
GB9028123D0 (en) * 1990-12-28 1991-02-13 Erba Carlo Spa Monoclonal antibodies against human tumor necrosis factor alpha
DE10199067I2 (de) * 1991-03-18 2006-03-16 Univ New York Fuer Menschlichen Tumornekrose-Faktor spezifische Monoklonale und Chimaere Antikoerper
CA2112907C (en) * 1991-07-05 2003-09-23 Deborah Ann Rathjen Peptide which abrogates tnf and/or lps toxicity
EP0525570A3 (en) * 1991-07-31 1993-10-06 Miles Inc. Anti-idiotypic antibodies that mimic tnf

Also Published As

Publication number Publication date
EP0568500A1 (en) 1993-11-03
ITRM920223A0 (it) 1992-03-27
ITRM920223A1 (it) 1993-09-27

Similar Documents

Publication Publication Date Title
DK0724456T3 (da) CD40-Antistoffer
ZA946767B (en) Monocional antibodies having property of causing apoptosis.
DK666389A (da) Monoklonalt antistof
FI963004A7 (fi) Vasta-aineen muodostumista kiihottavia monoklonaalivasta-aineita
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
IT8622630A0 (it) Anticorpi monoclonali crossreattivi e cross-protettivi contro sierotipi di p. aeruginosa.
DE3885355D1 (de) Monoklonale Antikörper.
DE3586216D1 (de) Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.
IT1254315B (it) Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf.
ITRM920506A0 (it) Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.
BR9509902A (pt) Fragmentos de anticorpos monoclonais apresentando atividade imunosupressante
DE3780256D1 (de) Anti-pci-monoklonaler antikoerper.
NO890116D0 (no) Monoklonale antistoffer.
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
NO873488L (no) Monoklonale antistoffer.
MX9202642A (es) Anticuerpos monoclonales y antigeno para melanoma humano.
ATE263784T1 (de) Anti-megakaryozyten monoklonaler antikörper 97a6
DE69023717D1 (de) Monoklonaler Antikörper.
DE69427850D1 (de) Monoklonaler antikörper gegen mucoglykoprotein
FI960566L (fi) Monoklonaalinen vasta-aine, joka tunnistaa välisolun pinta-antigeenin
FI893928A7 (fi) Monoklonala motkroppar.
DE69020315D1 (de) Monoklonaler antikörper gegen c-reaktives protein.
FI935038A7 (fi) Kasvaimiin liittyvä monoklonaalinen vasta-aine 81AV78
DE69324928D1 (de) Monoklonaler antikörper
DE68916088D1 (de) Anti-CPBII-monoklonaler Antikörper.